Thus, all eight methylation biomarker candidates (cg12799885, DOCK2, FBXO30, GRASP, HIF3A, MOB3B, PFKP and TPM4) displayed promising diagnostic potential for PCa. Here, DOCK2 is linked to posterior cortical atrophy.